Xilio Therapeutics (XLO) EPS (Basic) (2020 - 2026)
Xilio Therapeutics (XLO) reported EPS (Basic) of -$0.86 for Q1 2026, up 66.84% on a YoY basis from -$0.52 in Q1 2025, and up 39.09% sequentially from -$1.42 in Q4 2025.
Xilio Therapeutics (XLO) EPS (Basic) (2020 - 2026) Analysis & Trends
Xilio Therapeutics (XLO) has 7 years of EPS (Basic) data on file, last reported at -$0.86 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 66.84% year-over-year to -$0.86; the trailing twelve-month figure through Mar 2026 stood at -$2.59 (up 75.96% YoY), and the FY2025 full-year result was -$20.03, up 55.78% from the prior year.
- EPS (Basic) advanced to -$0.86 in Q1 2026, from -$1.42 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.19 in Q3 2025 to a low of -$12.69 in Q2 2022.
- A 5-year average of -$6.72 and a median of -$8.85 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) soared 98.21% in 2022 and fell 10.52% in 2023, its largest moves.
- Tracing XLO's EPS (Basic) over 5 years: stood at -$12.48 in 2022, then rose by 21.62% to -$9.78 in 2023, then surged by 62.8% to -$3.64 in 2024, then soared by 61.01% to -$1.42 in 2025, then soared by 39.09% to -$0.86 in 2026.
- Business Quant data shows XLO's EPS (Basic) at -$0.86 in Q1 2026, -$1.42 in Q4 2025, and -$0.19 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | 0.00 |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | 0.00 |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 1.55 |
| 10 | Xilio Therapeutics | 147.13 Mn | -3.17 Mn | - | -0.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.86 |
| Dec 31, 2025 | -1.42 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -2.09 |
| Mar 31, 2025 | -2.61 |
| Dec 31, 2024 | -3.64 |
| Sep 30, 2024 | -3.28 |
| Jun 30, 2024 | -3.61 |
| Mar 31, 2024 | -8.93 |
| Dec 31, 2023 | -9.78 |
| Sep 30, 2023 | -8.85 |
| Jun 30, 2023 | -10.29 |
| Mar 31, 2023 | -12.11 |
| Dec 31, 2022 | -12.48 |
| Sep 30, 2022 | -10.44 |
| Jun 30, 2022 | -12.69 |
| Mar 31, 2022 | -10.96 |
| Dec 31, 2021 | -49.08 |
| Sep 30, 2021 | -582.02 |
| Jun 30, 2021 | -439.25 |